Carregant...
Cisplatin and PI3Kinase Inhibition decrease Invasion and Migration of Human Ovarian Carcinoma Cells and regulate Matrix-Metalloproteinase Expression
Targeting of the PI3K (phosphoinositide3-kinase)/Akt/mTOR pathway in human ovarian cancer cells is a promising novel therapeutic strategy. We investigated the effects of cisplatin and the PI3K inhibitor LY294002 on invasion, migration and the expression of essential matrix metalloproteinases (MMPs)...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3001291/ https://ncbi.nlm.nih.gov/pubmed/20607860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cm.20465 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|